Our news

Our team, including Martin Holm-Petersen  (CEO), Jen Markey  (Chief Sales and Marketing Officer), Wilfred Gilich  (Vice President, US...

In 1996, MedDRA (Medical Dictionary for Regulatory Activities) was created to facilitate the international exchange of medical regulatory...

On 31st January 2022, the new EU Clinical Trials Regulation 536/2014 (CTR) entered into force and began a three-year transition period....

At Insife, we believe that every small action contributes to a sustainable future, and our commitment to environmental stewardship is...

The World Drug Safety Congress Europe was an incredible experience! On Wednesday, October 9, 2024, at 12:05 PM, our CEO, Martin...

On September 26th, the pharmacovigilance community gathered at the Novartis Campus for the Insife Annual Convention – a full-day...

Dr Arne Sprünken has had a successful 16-year career working for German pharmaceutical company Grünenthal and continues to thrive within...

In April 2021, the European Commission proposed the first EU regulatory framework for AI in order to ensure the safe, secure and ethical...

Peter Stroyer Pallesen was the first person employed by Insife when Martin Holm-Petersen started the company in 2017. After a long career...

Success in Pharmacovigilance Since our founding in 2017, we at Insife have dedicated ourselves to revolutionizing the field of...

Malin Kreitz is Insife’s new Business Development Director and brings a wealth of drug safety, PV and IT experience to her role. It all...

In an effort to ensure a smooth transition for our new joiners, our India offices in Noida and Bangalore organized a memorable...